Sentinel Lymph Node Biopsy Has No Benefit for Patients with Primary Cutaneous Melanoma Metastatic to a Lymph Node: An Assertion Based on Comprehensive, Critical Analysis
- 1 October 2003
- journal article
- review article
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 25 (5) , 399-417
- https://doi.org/10.1097/00000372-200310000-00006
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Improved Staging of Node-Negative Patients With Intermediate to Thick Melanomas (>1 mm) With the Use of Lymphatic Mapping and Sentinel Lymph Node BiopsyAnnals of Surgical Oncology, 2001
- Early Recurrence After Lymphatic Mapping and Sentinel Node Biopsy in Patients With Primary Extremity Melanoma: A Comparison With Elective Lymph Node DissectionAnnals of Surgical Oncology, 2001
- Frozen Section Investigation of the Sentinel Node in Malignant Melanoma and Breast CancerAnnals of Surgical Oncology, 2001
- Sentinel Lymph Node Biopsy for Melanoma: How Many Radioactive Nodes Should be Removed?Annals of Surgical Oncology, 2001
- Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)Annals of Surgical Oncology, 2000
- Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trialThe Lancet, 1998
- Gamma-probe guided localization of lymph nodesSurgical Oncology, 1993
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992
- The role of elective lymph node dissection in the management of patients with thick cutaneous melanomaCancer, 1990
- Lymph-node concentration of radioactive colloidal gold following interstitial injectionCancer, 1953